Michelle M. McGovern

Natural history of infantile‐onset spinal muscular atrophy

Craig McDonald, Christopher S Coffey, Seward B Rutkove, 2017, Annals of neurology.

Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis

Sridar Narayanan, Ken E Sakaie, Mark J Lowe, 2018, The New England journal of medicine.

Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.

J. Long, R. Conwit, S. Shinnar, 2016, Contemporary clinical trials.

Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis.

Gary L. Pattee, Samuel P. Dickson, Stephen A. Goutman, 2020, The New England journal of medicine.

Long‐term survival of participants in the CENTAUR trial of sodium phenylbutyrate‐taurursodiol in amyotrophic lateral sclerosis

Gary L. Pattee, Samuel P. Dickson, Stephen A. Goutman, 2020, Muscle & nerve.

Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study

R. Finkel, M. Cudkowicz, S. Rutkove, 2016, Annals of clinical and translational neurology.

Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA!

M. Cudkowicz, C. Coffey, W. Arnold, 2018, Contemporary clinical trials communications.